India: Regulatory Guidelines For E-Pharmacy Start-Ups

An ePharmacy is an online pharmacy, Internet pharmacy or mail-order pharmacy that operates over the Internet and sends the orders to customers through the mail or shipping companies. In India ePharmacy sector is in its growing stage, whereas in US and Europe it is fully functional and regularized. In recent years ePharmacy startups in India has been rising at a steady pace, with focus to deliver affordable medicines to anyone who needs it, and to supply the medicines in remote areas where physical drug stores are not present. Moreover, the present ePharmacy stores not only sell medicines but also offer other facilities like - list of diagnostic (pathological/radiological) test bookings, online consultation to the Physician, and consumer education through value added information/ educational leaflets/articles on their websites.

However, it's been observed that the offline/physical pharmacy community has been opposing the ePharmacy business model, and a nationwide strike against the e-pharmacies was performed under the leadership of All India Organization of Chemists & Druggists (AIOCD). According to the retail chemist shop owners as cited in Indian express "verification of drug quality in online retail is difficult and the sale of psychotropic substances will also increase online". In response to this, the Indian Internet Pharmacy Association (IIPA) a self-regulatory body for e-Pharma portals said that, the e-pharmacies will enable transparent drug dispensing mechanism and give high accountability as the entire procedure will be tracked.

Apart from this, the present drug regulation in India resides under Drugs and Cosmetics Act, 1940, Drugs and Cosmetics Rules, 1945, Pharmacy Act, 1948, Indian Medical Act, 1956 and Code of Ethics Regulations, 2002, Information Technology (IT) Act, 2000 etc..The powers of regulation have been distributed between the centre and the state governments. Central Government is responsible for licensing of drug imports and the state governments are responsible for the manufacture, sale and distribution of drugs. Every state has its own Drugs Control Administration1.

However, the Drugs and Cosmetics Act, 1940 does not differentiate between medicines sold online or offline; there is no solid regulation/policy available to regulate ePharmacy operation in India. Therefore, the health ministry and Central Drug Standard control Organization (CDSCO) have been working together on ePharmacy regulation policy, which is expected to streamline the online sales of medicine. Despite this the present developments of entrepreneurial ventures in ePharmacy Sector has already established the ePharmacy success story for a greater cause. In this view, the IIPA in the absence of ePharmacy policy by the government announced a voluntary "Code of Conduct", as this Code complies with existing Drug and Cosmetic Act, 1940 suggests that-

  • The e-pharmacies will only process scheduled medicines (Schedule H, H1) against a valid physical or scanned copy of the prescription. They will not process schedule X and other habit forming medicines.
  • The e-pharmacies will only dispense medicines through licensed pharmacies and will deliver medicines "safely and with appropriate instructions", according to the code.

Online medicine sellers will also partner with the government to recall medicines, raise awareness on the Jan Aushadhi scheme and also compile adverse events of medicines for the National Centre for Pharmacovigilance2.

Moreover, The Draft Pharmaceutical Policy of 2017 also encourages ePharmacies, and seeks to take on the powerful distribution lobby by allowing e-pharmacies, which will cut down channel costs3.

The Central Drugs Standard Control Organization (CDSCO) and ePharmacy

The Drugs Consultative Committee (DCC) of CDSCO is a statutory body constituted under Section 7 of the Drugs and Cosmetics Act, 1940. The DCC is authorized to maintain the uniformity of Drug and Cosmetic Act, 1940 throughout the country. In regards ePharmacy, the DCC on 11 Aug 2015 constituted a sub-committee of seven members headed by Mr. Harshdeep Kamble, Commissioner, FDA, Maharashtra, to examine the issue of sale of drugs on the internet in the light of practices being followed in the developed countries where such provisions are available for e-pharmacies, while taking care the risks and concerns related to such sales.

Meanwhile, On 30 December 2015, The CDSCO notified that selling of drugs through internet is not permitted as it violates the provisions of the Drugs & Cosmetics Act, 1940 and the Rules, 1945,4 and the status stands same at present as reported in the minutes of 50th DCC meeting held on 5th November, 2016.

The sub-committee had invited suggestions /views on online pharmacy regulation, further received suggestions/views regarding the same from various stakeholders, medical and Pharma associations, regulatory agencies, trade organizations & companies etc. It also received around 368 representations from individuals and other organizations, As few of these suggestions are highlighted below-

Associations Suggestions/views regarding ePharmacy
Indian Internet Pharmacy Association (IIPA) The association gave a detailed presentation on advantages of online mode of sale and also advocated that the market place and electronic platforms are in line with the provisions of the Information Technology Act, 2000 and Pharmacy Practice Regulation 2015. They also reiterated that the sale of medicines does not violate prevailing provisions of the Act.
Federation of Indian Chambers of Commerce & Industry (FICCI) FICCI gave a detailed presentation on advantages of this mode of sale and also advocated that the market place and electronic platforms are in line with the provisions of the Information Technology Act, 2000 and Pharmacy Practice Regulation 2015. They also reiterated that the sale of medicines through online mode do not violate prevailing provisions of the Act.
Indian Pharmaceutical Alliance (IPA) The changes in the present statute shall be made to ensure that online pharmacy players shall deliver against every order and should not be selective. It should be mandatory to cater and deliver to the remote and rural areas of the country. They said that this mode of sale will increase the accessibility of the medicines in general.
Organization of Pharmaceutical Producers of India (OPPI) Although online pharmacy have some advantages such as medicines being available at reduced cost, reduced inventory but cautioned on entry of counterfeit and spurious medicines. The system should ensure the traceability of the medicines.
Indian Medical Association (IMA) The sale of medicines over internet will further contribute this menace. IMA is not in favor of encouraging this mode of making availability of medicines. The prescriptions on the electronic platforms should be verifiable.
Consumer Online Foundation, New Delhi The foundation has submitted the copy of written representation and points for consideration. While accepting the online pharmacy that the technology advancements are inevitable, but it has to be taken with caution and with certain safeguards.
P h a r m a c y Council of India (PCI) The Pharmacy Practice Regulations have been made by Pharmacy Council of India, with approval of the Central Government, as powers conferred under Section 10 and 18 of the Pharmacy Act, 1948. While dispensing the medicines whether online or offline, the provisions under these regulations have to be considered.
All India organization of Chemist and Druggist Association (AIOCDA) The association out rightly opposed the concept of online sale of medicine. The concerns raised by the associations on online sale with a detailed power point and written presentation:
All India Drug Control Officer's Confederation (AIDCOC) This activity should be covered under the Drugs and Cosmetics Act, 1940 and rules 1945 with specific amendments to it.

The sub-committee after going through the suggestions, and considering the international practices followed in some of the major countries and also keeping the existing provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 made there under, Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, Drug Price Control Order (DPCO), 2013, IT Act, 2000 etc. made 22 points recommendation in its report: as some of them are suggesting-

EPharmacy may be permitted under strict monitoring and vigilance with effective law enforcement and period inspections. It also suggests some geographical restrictions for supply of drugs will be required for effective administrative control on online sale such as drug recalls and Pharmacovigilance.

In order to regulate online pharmacies, a National Portal will be created, which will be the nodal platform for transacting and monitoring online sale of drugs. Whereas the e-pharmacy service providers need to be registered with Central Drugs Standard Control Organization (CDSCO) under the Drugs and Cosmetics Rules, 1945. No unregistered entity shall be permitted to undertake online sale of medicines.

However the Sub-committee also suggested amendments in the Drugs and Cosmetics Rules, 19455.

Conclusion :

In 50th meeting of DCC, the committee accepted the report of the Sub-committee that the report should be forwarded to the Govt. for consideration and further action6.

At Present, the leading ePharmacy players such as- 1mg, Netmeds, mChemist, Myra, Medlife, PharmaEasy Medidart as many as 140 startups are currently operating in the online pharmacy market. There is an immediate need to have effective regulatory mechanism as the delay in process is not beneficial for the e-pharmacy service providers and consumers as well.








The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.